Summary
GlobalData's clinical trial report, “Trigeminal Neuralgia Global Clinical Trials Review, H2, 2016" provides an overview of Trigeminal Neuralgia clinical trials scenario. This report provides top line data relating to the clinical trials on Trigeminal Neuralgia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Biogen, Inc.
Allergan Plc
Merz GmbH & Co. KGaA
Pfizer Inc.
Parexel International Corporation
Norton Healthcare, Inc.
Allodynic Therapeutics, LLC
Grifols, S.A.
Desitin Arzneimittel GmbH
Capnia, Inc.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Top Countries Contributing to Clinical Trials in Middle East and Africa 11
Top Countries Contributing to Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries: Proportion of Trigeminal Neuralgia to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Trigeminal Neuralgia to Central Nervous System Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Trigeminal Neuralgia Therapeutics Clinical Trials 24
Prominent Drugs 26
Clinical Trial Profile Snapshots 27
Appendix 42
Abbreviations 42
Definitions 42
Research Methodology 43
Secondary Research 43
About GlobalData 44
Contact Us 44
Disclaimer 44
Source 45
List of Tables
Trigeminal Neuralgia Therapeutics, Global, Clinical Trials by Region, 2016* 5
Trigeminal Neuralgia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Trigeminal Neuralgia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Trigeminal Neuralgia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 8
Trigeminal Neuralgia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9
Trigeminal Neuralgia Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
Trigeminal Neuralgia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11
Trigeminal Neuralgia Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 12
Proportion of Trigeminal Neuralgia to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 13
Trigeminal Neuralgia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Trigeminal Neuralgia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Trigeminal Neuralgia to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 16
Trigeminal Neuralgia Therapeutics, Global, Clinical Trials by Phase, 2016* 17
Trigeminal Neuralgia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 18
Trigeminal Neuralgia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
Trigeminal Neuralgia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
Trigeminal Neuralgia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
Trigeminal Neuralgia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 22
Trigeminal Neuralgia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
Trigeminal Neuralgia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 25
Trigeminal Neuralgia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26
List of Figures
Trigeminal Neuralgia Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Trigeminal Neuralgia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Trigeminal Neuralgia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Trigeminal Neuralgia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 8
Trigeminal Neuralgia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9
Trigeminal Neuralgia Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10
Proportion of Trigeminal Neuralgia to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 13
Trigeminal Neuralgia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
Trigeminal Neuralgia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
Proportion of Trigeminal Neuralgia to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 16
Trigeminal Neuralgia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 17
Trigeminal Neuralgia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 18
Trigeminal Neuralgia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 19
Trigeminal Neuralgia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 20
Trigeminal Neuralgia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 21
Trigeminal Neuralgia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 22
Trigeminal Neuralgia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 23
Trigeminal Neuralgia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 24
Trigeminal Neuralgia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 26
GlobalData Methodology 43
